Oncology & Cancer

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

Medications

Adding omega-3 fatty acids does not cut high CV risk

(HealthDay)—A carboxylic acid formulation of eicosapentaenoic acid and docosahexaenoic acid (omega-3 CA) does not improve outcomes among statin-treated patients at high cardiovascular risk, according to a study published ...

Obstetrics & gynaecology

Ibuprofen does not increase postpartum blood pressure

(HealthDay)—Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, do not increase blood pressure among postpartum women with hypertensive disorders of pregnancy, according to a study published online Nov. 4 ...

Medications

Dabigatran doesn't beat aspirin for preventing recurrent stroke

(HealthDay)—Dabigatran is not superior to aspirin for preventing recurrent stroke in patients with recent history of embolic stroke of undetermined source, according to a study published in the May 16 issue of the New England ...

page 1 from 2